Regulation 2 Amendment of the Pharmaceutical Regulations

(1)

Regulation 2 of the Pharmaceutical Regulations (interpretation) is amended in accordance with paragraphs (2) to (4).

(2)

In paragraph (1)—

(a)

omit the definition of “Board”;

(b)

in the definition of “dispensing doctor”, for “the Board” substitute “the Department”;

(c)

after the definition of “Drug Tariff”, insert—

““FPSIAP” means the Family Practitioner Services Independent Appeal Panel established under regulation 3 of the Health and Social Care (Family Practitioner Services Independent Appeal Panel) Regulations (Northern Ireland) 2022^f1;”;

(d)

in the definitions of “Local Dental Committee”, “Local Medical Committee” and “Local Pharmaceutical Committee” for “a Board” substitute “the Department”;

(e)

in the definition of “patient list”, for “a Board” substitute “the Department”; and

(f)

in the definition of “repeatable prescriber”, for “the Regional Board” substitute “the Department”.

(3)

In paragraph (1A)^f2 omit “who are in a Board’s area”.

(4)

For paragraph (4) substitute—

“(4)
In these Regulations, “emergency requiring the flexible provision of pharmaceutical services” means an emergency to the effect that, as a result of the threatened damage to human welfare caused by illness or which may be caused by illness, the Department must for a specified period—

(a)
exercise, or

(b)
where a discretion is conferred, consider exercising,

one or more of the functions under regulation 6A, 12(7A) or paragraph 4A of Schedule 2 subject to any conditions or limitations.”.

Annotations

Footnotes

f1: S.R. 2022 No. 109
f2: Paragraph (1A) was inserted by S.R. 1999 No. 100